Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Mechanisms of Disease: local renin–angiotensin–aldosterone systems and the pathogenesis and treatment of cardiovascular disease

Nature Clinical Practice Cardiovascular Medicine volume 1, pages 42–47 (2004)Cite this article

Abstract

Accumulating evidence has made it clear that not only does the renin–angiotensin–aldosterone system (RAAS) exist in the circulation where it is driven by renal renin, but it is also active in many tissues—and likely within cells as well. These systems might not be completely independent of each other, but rather interact. These local RAASs affect tissue and cellular angiotensin II concentrations and appear to be associated with clinically relevant physiologic and pathophysiologic actions in the cardiovascular system and elsewhere. Evidence in support of this possibility is reviewed here. In addition, direct (pro)renin action after binding to its specific receptor, the existence of renin transcripts, which apparently encode an intracellular renin, the discovery of an angiotensin-converting-enzyme homologue (ACE2), which leads to enhanced generation of angiotensin-(1–7) and the newly appreciated role of angiotensin-receptor dimerization in the regulation of angiotensin activity, all point to the conclusion that the RAASs are complexly regulated, multifunctional systems with important roles both within and outside the cardiovascular system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The renin–angiotensin cascade

Similar content being viewed by others

References

  1. Re RN (1987) The renin-angiotensin systems. Med Clin North Am 71: 877–895

    Article  CAS  Google Scholar 

  2. Brenner BM et al. and RENAAL Study Investigators (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861–869

    Article  CAS  Google Scholar 

  3. Lip GY and Beevers DG (2003) More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2). J Hum Hypertens 17: 747–750

    Article  CAS  Google Scholar 

  4. Poulsen PL (2003) ACE inhibitor intervention in type 1 diabetes with low grade microalbuminuria. J Renin Angiotensin Aldosterone Syst 4: 17–26

    Article  CAS  Google Scholar 

  5. Rajagopalan S and Pitt B (2003) Aldosterone as a target in congestive heart failure. Med Clin North Am 87: 441–457

    Article  CAS  Google Scholar 

  6. Re RN (2004) Tissue renin angiotensin systems. Med Clin N Am 88: 19–38

    Article  CAS  Google Scholar 

  7. Von Lutterotti N et al. (1994) Renin is not synthesized by cardiac and extra renal vascular tissues: review of experimental evidence. Circulation 89: 458–470

    Article  CAS  Google Scholar 

  8. Nguyen G et al. (1996) Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109: 1417–1427

    Article  Google Scholar 

  9. Nguyen G et al. (1996) Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 50: 1897–1903

    Article  CAS  Google Scholar 

  10. Saris JJ et al. (2001) Cardiomyocytes bind and activate native prorenin: role of soluble mannose 6-phosphate receptors. Hypertension 37: 710–715

    Article  CAS  Google Scholar 

  11. Peters J et al. (2002) Functional significance of prorenin internalization in the rat heart. Circ Res 90: 1135–1141

    Article  CAS  Google Scholar 

  12. Clausmeyer S et al. (1999) An alternative transcript of the rat renin gene can result in a truncated prorenin that is transported into adrenal mitochondria. Circ Res 84: 337–344

    Article  CAS  Google Scholar 

  13. Lee-Kirsch MA et al. (1999) Distinct renin isoforms generated by tissue-specific transcription initiation and alternative splicing. Circ Res 1999 84: 240–246

    Article  CAS  Google Scholar 

  14. Sinn PL and Sigmund CD (2000) Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics 3: 25–3175

    Article  CAS  Google Scholar 

  15. Peters J et al. (1999) Losatan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system. Endocrinology 140: 675–682

    Article  CAS  Google Scholar 

  16. Dostal DE and Baker KM (1999) The cardiac renin-angiotensin system: conceptual, or regulator of cardiac function? Circ Res 85: 643–650

    Article  CAS  Google Scholar 

  17. Nussberger J (2001) Circulating versus tissue angiotensin II. In Angiotensin II Receptor Antagonists, 69–78 (Eds, Epstein M and Brunner HR) Philadelphia: Hanley and Belfus

    Google Scholar 

  18. Serneri GGN et al. (1996) Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation 94: 1886–1896

    Article  CAS  Google Scholar 

  19. Serneri GGN et al. (2001) Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 88: 961–971

    Article  CAS  Google Scholar 

  20. Delcayre C et al. (2000) Cardiac aldosterone production and ventricular remodeling. Kidney Int 57: 1346–1351

    Article  CAS  Google Scholar 

  21. Harada E et al. (2001) Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 104: 137–139

    Article  CAS  Google Scholar 

  22. Mizuno Y, et al. (2001) Aldosterone production is activated in failing ventricle in humans. Circulation 103: 72–77

    Article  CAS  Google Scholar 

  23. Yamamoto N et al. (2002) Aldosterone is produced from ventricles in patients with essential hypertension. Hypertension 39: 958–962

    Article  CAS  Google Scholar 

  24. Robertson AI and Khairallah PA (1971) Angiotensin rapid localization in nuclei of smooth and cardiac muscle. Science 172: 1138–1140

    Article  CAS  Google Scholar 

  25. Re RN (1989) The cellular biology of angiotensin: paracrine, autocrine and intracrine actions in cardiovascular tissues. J Mol Cell Cardiol 21 (suppl V): 63–69

    Article  CAS  Google Scholar 

  26. De Mello WC (1995) Influence of intracellular renin on heart cell communication. Hypertension 25: 1172–1177

    Article  CAS  Google Scholar 

  27. De Mello WC (2001) Cardiac arrhythmias: the possible role of the renin-angiotensin system. J Mol Med 79: 103–108

    Article  CAS  Google Scholar 

  28. Haller H et al. (1999) Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol 10 (suppl 11): S75–83

    CAS  PubMed  Google Scholar 

  29. Erdmann B et al. (1996) Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex. Hypertension 28: 818–824

    Article  CAS  Google Scholar 

  30. Chen R et al. (2000) A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Renal Physiol 279: F440–448

    Article  CAS  Google Scholar 

  31. Re RN (2003) The intracrine hypothesis and intracellular peptide hormone action. Bio Essays 25: 401–409

    CAS  Google Scholar 

  32. Re RN and Bryan SE (1984) Functional intracellular renin- angiotensin systems may exist in multiple tissues. Clin Exp Hyperten A 6 (10–11): 1739–1742

    Google Scholar 

  33. Re RN (2003) Intracellular renin and the nature of intracrine enzymes. Hypertension 42: 117–122

    Article  CAS  Google Scholar 

  34. Mercure C et al. (1998) Evidence for intracellular generation of angiotensin II in rat juxtaglomerular cells. FEBS Lett 422: 395–399

    Article  CAS  Google Scholar 

  35. Bunnemann B et al. (1993) The renin angiotensin system in the brain: an update 1993. Regul Pept 46: 487–509

    Article  CAS  Google Scholar 

  36. Lavoie JL et al. (2004) Adjacent expression of renin and angiotensinogen in the rostral ventrolateral medulla using a dual-reporter transgenic model. Hypertension 43: 1116–1119

    Article  CAS  Google Scholar 

  37. Steckelings UM et al. (2004) Human skin: source of and target organ for angiotensin II. Exp Dermatol 13: 148–154

    Article  CAS  Google Scholar 

  38. Okada H et al. (2002) Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney. Am J Pathol 160: 765–772

    Article  CAS  Google Scholar 

  39. Frustaci A et al. (2000) Myocardial cell death in human diabetes. Circ Res 87: 1123–1132

    Article  CAS  Google Scholar 

  40. Re RN (2001) The clinical implication of tissue renin angiotensin systems. Curr Opin Cardiol 16: 317–327

    Article  CAS  Google Scholar 

  41. Mazzolai L et al. (1998) Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 31: 1324–1330

    Article  CAS  Google Scholar 

  42. Scholkens BA and Landgraf W (2002) ACE inhibition and atherogenesis. Can J Physiol Pharmacol 80: 354–359

    Article  CAS  Google Scholar 

  43. Morishita R et al. (2000) Antisense oligodeoxy-nucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function. Arterioscler Thromb Vasc Biol 20: 915–922

    Article  CAS  Google Scholar 

  44. Wang CH et al. (2003) C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107: 1783–1790

    Article  CAS  Google Scholar 

  45. AbdAlla S et al. (2001) Increased AT(1) receptor heterodimers in preeclampsia medicate enhanced angiotensin II responsiveness. Nat Med 7: 1003–1009

    Article  CAS  Google Scholar 

  46. AdbAlla S et al. (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276: 39721–39726

    Article  Google Scholar 

  47. Singh BM and Mehta JL (2003) Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Arch Intern Med 163: 1296–1304

    Article  CAS  Google Scholar 

  48. Brosnihan KB et al. (1998) Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res 31: 227–234

    CAS  PubMed  Google Scholar 

  49. Crackower MA et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 799–802

    Article  Google Scholar 

  50. Kida T et al. (2003) Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human muller cells. Jpn J Ophthalmol 47: 36–41

    Article  CAS  Google Scholar 

  51. Juillerat-Jeanneret L et al. (2004) Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer 90: 1059–1068

    Article  CAS  Google Scholar 

  52. Cook J et al. (1992) The use of antisense oligonucleotides to establish autocrine angiotensin growth effects in human neuroblastoma and mesangial cells. Antisense Nucleic Acid Drug Dev 2: 199–210

    CAS  Google Scholar 

  53. Strawn WB et al. (2004) Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 126: 120–12655

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. the Vice President and Director of Research at the Ochsner Clinic Foundation, New Orleans, LA, USA

    Richard N Re

Authors
  1. Richard N Re
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard N Re.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Re, R. Mechanisms of Disease: local renin–angiotensin–aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Nat Rev Cardiol 1, 42–47 (2004). https://doi.org/10.1038/ncpcardio0012

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0012

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing